Pedro Cepas

1.4K posts

Pedro Cepas banner
Pedro Cepas

Pedro Cepas

@pedro_cepas

Interventional Cardiologist @HospitalClinic | Structural Heart Fellowship @IUCPQ | PhD @UniBarcelona | MD @UAM_Medicina

Barcelona, Spain Beigetreten Nisan 2019
1.1K Folgt2.1K Follower
Pedro Cepas retweetet
Ivo Roca, FEHRA, FESC
Ivo Roca, FEHRA, FESC@ivroca·
Recently published in @CircAHA our long-term PAM-VT2 study: Post-ablation MRI to predict long-term VT recurrence, to assess scar evolution, new +remodelling effect after ablation proved! A long journey working together EP, imaging, bioengineers. clinicbarcelona.org/en/news/cardia…
Ivo Roca, FEHRA, FESC tweet media
English
5
32
94
6.4K
Pedro Cepas retweetet
NEJM
NEJM@NEJM·
Early surgery in asymptomatic patients with very severe aortic stenosis led to a lower risk of a composite of operative mortality or death from cardiovascular causes at 10 years than conservative care. Full RECOVERY trial results: nejm.org/doi/full/10.10…
NEJM tweet media
English
6
158
486
59.3K
Pedro Cepas
Pedro Cepas@pedro_cepas·
Balloon-or self-expanding for small ViV TAVR? 🤔 3-year results from the LYTEN trial 🔥 Just published in @CircIntv 👇👇
Pedro Cepas tweet media
English
3
9
34
7.3K
Pedro Cepas retweetet
Eduardo Flores-Umanzor
Eduardo Flores-Umanzor@ejfu0209·
We are more than happy to be part of this review on transcatheter interventions in adults with TGA. Truly grateful for the expertise, hard work, and insights of all the coauthors—this work wouldn’t have been possible without them. @erichorlick @hospitalclinic @Raquel_lunalop
Eduardo Flores-Umanzor tweet media
English
1
3
9
524
Pedro Cepas
Pedro Cepas@pedro_cepas·
One-year results from the ADALA trial — presented as LBCT by @freixa_xavier at PCR London Valves 2025 🇬🇧 — coming soon in @RevEspCardiol
Pedro Cepas tweet media
PCRonline 🫀@PCRonline

🔥#PCRLV 2025 Top Late-Breaking Trial results: Managing patients with high thrombotic but also high bleeding risk is a persistent challenge. Left atrial appendage occlusion (LAAO) reduces both thrombotic and bleeding risks in selected patients, however, how to manage the early post-procedure period has remained unclear. 1-year results of the ADALA Trial, presented by @freixa_xavier, in London, show that low-dose Apixaban may be a safer and more effective alternative to conventional therapy

English
0
6
37
8.9K
Pedro Cepas
Pedro Cepas@pedro_cepas·
#PCRLV 🇬🇧 is about to start and @hospitalclinic will be very present: – 6‼️Hot Lines/LBCT 🔥🔥 trials will be presented by the IC section – Participation in tricuspid, mitral, and LAAC sessions @masitges @lsanchisruiz – Best abstracts 🌉and clinical case presentations @a_rubi_5
English
3
8
22
1.3K
Carla Benavent
Carla Benavent@carla_benavent·
¿Qué mejor forma de despedir al gran @CMGiuliani tras su enorme paso por el @IUCPQ que con una formación en Orbital con todos sus compañeros? 😉 Te echaremos de menos, amigo. Argentina tiene de vuelta a uno de sus mejores👨🏻‍⚕️🇦🇷 #JeMeSouviens 🇨🇦
Carla Benavent tweet media
Español
2
2
5
1K
Pedro Cepas retweetet
Salvatore Brugaletta
Salvatore Brugaletta@sbrugaletta·
Today we had the pleasure and honor to host prof. Wijns at @hospitalclinic to give us a lecture about “the illusion of PCI”: when to implant a stent based on angiography is not enough for treating a patient. Thank you so much! @masitges @PCRonline
Salvatore Brugaletta tweet media
English
0
11
34
3.1K
Pedro Cepas retweetet
Giovanni Occhipinti
Giovanni Occhipinti@drgocchipinti·
Aortic valve calcification critically influences the outcomes of #TAVI, with extensive burden consistently linked to higher rates of #PVL, which itself is associated with increased #mortality. In our study, we applied a quantitative evaluation using CT-derived Agatston scoring, defining severe calcification as ≥3000 AU. Here the article: doi.org/10.1016/j.cjca… Thanks to @AnderRegueiro and @AndreaRuberti
Giovanni Occhipinti tweet media
English
0
3
9
739

Entdecken

@CircAHA @hospitalclinic @escardio @AgudosSEC @PCRonline @atari_bcn @jmcampis @salutcat